SHARESIFT
Healthcare · data ~15-min delayed
1,801 INR -0.86%
| Price | 1,801 INR |
| Day change | -0.86% |
| Market cap | 4.32T |
| 52-week range | 1,583.7 – 2,046.9 |
| P/E (trailing) | 35.7 |
| Dividend yield | 0.89% |
| Payout ratio | 31.75% |
| Debt / equity | 6% |
| Beta | 0.12 |
| Sector | Healthcare |
| Value score | 17 / 100 |
How the value score is calculated: 13 published tests, weighted to 100.
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) scores 17/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It trades at 35.7 times trailing earnings and is classified in Healthcare. The dividend yield is 0.89%, paid from 32% of earnings. On its filings it passes 5 of the nine Piotroski checks, a mixed picture. Its Altman Z-Score places it in the safe zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 5 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 12.71 — Safe zone.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: India stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.
RELIANCE.NSTCS.NSHDFCBANK.NSINFY.NSICICIBANK.NSHINDUNILVR.NSITC.NSSBIN.NS